Rock Springs Capital Management’s Kite Pharma, Inc. KITE Stock Holding History

Rock Springs Capital Management’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-68,000	Closed	-$12.2M	–	156
2017 Q3	$12.2M	Buy	68,000 +500	+0.7%	+$69.7K	0.56%	60
2017 Q2	$7M	Buy	67,500 +500	+0.7%	+$40.8K	0.35%	83
2017 Q1	$5.26M	Sell	67,000 -12,000	-15%	-$742K	0.3%	89
2016 Q4	$3.54M	Hold	79,000	–	–	0.24%	93
2016 Q3	$4.41M	Sell	79,000 -1,000	-1%	-$55.7K	0.28%	94
2016 Q2	$4M	Hold	80,000	–	–	0.3%	91
2016 Q1	$3.67M	Hold	80,000	–	–	0.31%	92
2015 Q4	$4.93M	Sell	80,000 -11,500	-13%	-$809K	0.37%	87
2015 Q3	$5.09M	Sell	91,500 -26,500	-22%	-$1.67M	0.41%	79
2015 Q2	$7.19M	Buy	118,000 +46,526	+65%	+$2.65M	0.53%	71
2015 Q1	$4.12M	Sell	71,474 -43,000	-38%	-$2.88M	0.39%	82
2014 Q4	$6.6M	Buy	114,474 +32,000	+39%	+$1.35M	0.77%	49
2014 Q3	$2.35M	Buy	+82,474	New	+$2.04M	0.36%	73

Rock Springs Capital Management's KITE Position: Q4 2017 in Review

Rock Springs Capital Management sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 68,000 shares — an estimated $12.2M sold.

Rock Springs Capital Management first reported a position in KITE in Q3 2014 and held it in 13 quarters. The position peaked at $12.2M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Rock Springs Capital Management reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Rock Springs Capital Management sold 68,000 Kite Pharma, Inc. shares in Q4 2017, an estimated $12.2M.
Rock Springs Capital Management first reported a position in Kite Pharma, Inc. in Q3 2014 and held it in 13 quarters.
Rock Springs Capital Management's Kite Pharma, Inc. position peaked at $12.2M in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Rock Springs Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.